Solasia Pharma K.K. (TSE : 4597) acquired Episil oral liquid business from Camurus AB (OM : CAMX).
Solasia Pharma K.K. (TSE : 4597) completed the acquisition of Episil oral liquid business from Camurus AB (publ) (OM : CAMX) on July 8, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28 JPY | 0.00% | +7.69% | -37.78% |
1st Jan change | Capi. | |
---|---|---|
-37.78% | 32.59M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-9.06% | 33.03B | |
+55.32% | 24.68B | |
-16.61% | 15.12B | |
-9.14% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |